Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-1-27
pubmed:abstractText
The inflammation marker YKL-40 is elevated in patients with type 2 diabetes and is associated with atherosclerosis and increased cardiovascular mortality. In the present study, YKL-40 levels were examined in patients with type 1 diabetes with increasing levels of albuminuria, known to be associated with an increased risk of cardiovascular disease.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-10388530, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-10391393, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-10446083, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-11466120, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-11877368, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-11950696, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-12663607, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-12774166, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-15692810, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-16033329, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-16164620, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-16612564, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-16955240, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-17087877, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-17627189, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-17686944, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-18157633, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-18332153, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-18480670, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-2668076, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-3086326, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-7768902, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-8259139, http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-8432214
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1935-5548
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
323-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.
pubmed:affiliation
Department of Endocrinology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark. cnr@dadlnet.dk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't